Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Home
/
update
/
details

IMA Launches National Alliance to Combat Antimicrobial Resistance

NextEdge Admin

12 Jul 2024

2 min 38 sec

The Indian Medical Association (IMA) has initiated the National Alliance of Medical Professionals on Antimicrobial Resistance (NAMP-AMR) to combat the growing threat of Antimicrobial Resistance (AMR). This alliance unites leaders and representatives from 52 medical specialty organizations nationwide, marking the start of a coordinated national effort to address this critical health issue.

AMR is a significant threat, causing 297,000 deaths and contributing to 1,042,500 deaths in India in 2019. Dr. Narendra Saini, Chairman of IMA AMR, described it as a “silent pandemic” requiring urgent action. “The formation of NAMP-AMR by the IMA signifies the beginning of a focused national effort to tackle this crisis,” he stated.

Dr. VK Paul from NITI Aayog reinforced the government’s commitment to addressing AMR, highlighting its potential impact on Viksit Bharat, GDP, and overall health. He praised the IMA’s initiative as a crucial step in transforming this effort into a national movement by uniting all organizations under one banner.

Payden, Deputy Head of WHO India, emphasized the global urgency of addressing AMR, projecting it as a leading cause of death by 2050. She stressed the need for a collaborative approach. Dr. Anuj Sharma, Team focal point for AMR & IPC, WHO, thanked the 52 organizations for forming NAMP-AMR.

Enhanced medical education and training are essential for improving medical practice and combating AMR. Dr. Atul Goel, Director General of Health Services, highlighted the importance of understanding when and how to use antibiotics effectively, starting from basic medical education.

The IMA’s initiative aims to lead global efforts in mitigating the impact of AMR through collaborative efforts, strategic planning, and governmental support.